A study tied stem cell transplant in RRMS patients with reductions in biomarkers linked to disease progression.

Presentation to highlight the Company's proprietary protein-misfolding platform, EpiSelectTM, used to develop PMN310 Posters highlighting PRECISE-AD, the Company's Phase 1b clinical trial design and ...

Relief Therapeutics Holding SA / Key word (s): Mergers Acquisitions Relief Therapeutics Announces Proposed Business ...

The three judges on the panel, all appointed by Democratic presidents, appeared disinclined to grant the Trump administration's request.

A team of scientists analyzed data from over a dozen studies involving more than 900 people with MS to research iron rim ...

Six months ago, I took a leap into the unknown, writes DONAL MACINTYRE. After tipping the scales the other way, here I reveal ...

Hulk Hogan's widow Sky Daily Hogan has spoken out following the shock death of her wrestling pro husband, who died at the age of 71. In a heartbreaking message shared with fans on Instagram, Sky said ...

The orange and black napkins in the water glasses at Darcy’s Restaurant in Spokane Valley marked the table of a special group ...

Researchers are one step closer to finding a common target for treating ALS - a fatal neurodegenerative disease that causes ...

MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange ...

In a measure that flouts the FDA, Florida says doctors can give unapproved stem-cell therapies for wound care, pain ...

MN-166 COMBAT ALS trial down to single digit required enrollment while MN-001 hypertriglyceridemia trial in type 2 diabetes ...